date:Jul 21, 2012
it is planning more trials with 3-400 patients at 40 sites across the US over a six month period.
A strategic step forward in building up our brain health portfolio
Accera is a privately-held company which specializes in medical foods for people with neurodegenerative disorders such as AD.
Nestles input will help the firm expand its clinical development program and strengthen its commercial capabilities in the US, said president and CEO Holger Kunze.
Longer term, it will also give us the op